Should you buy Stepan (SCL)?
Updated
Stepan Company is a specialty chemicals company trading at a forward price-to-earnings of 13.9x with a PEG of 0.02 and 38% analyst upside, and has broken out above all major moving averages, but business quality is below the minimum threshold at 2.2 out of 10 with 3 consecutive earnings misses, creating a fundamental quality barrier to full conviction.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
| Pillar | Expectation | Trend |
|---|---|---|
The stock trades at a PEG ratio of 0.02 — effectively zero — and a forward price-to-earnings of 13.9x against a peer group where the stock screens as the top value name, with analysts targeting a price approximately 38% above the current $54.47. Valuation breakdown | Price rises above $63, more than 15% above the current $54.47, within 12 months as the valuation discount begins to close. | →Stable |
| CounterAn extremely low PEG ratio alongside consecutive earnings misses often indicates the growth estimate that forms the denominator is not achievable; the cheap multiple may persist because the growth required to justify it is unlikely to materialize. | ||
The stock has crossed into a golden cross breakout pattern — above all major moving averages with RSI at 61 and MACD bullish — and shows rising on-balance volume accumulation, suggesting institutional buyers are building positions ahead of a potential fundamental recovery. V9 | Price holds above the 200-day moving average and RSI stays above 50 for at least 60 consecutive trading days. | →Stable |
| CounterTechnical breakouts driven by accumulation in low-quality stocks can reflect speculative rotation rather than fundamental improvement; without earnings quality improvement, breakouts in below-minimum-quality companies have a higher failure rate. | ||
Business quality is at 2.2 out of 10, with near-zero scores on return on equity, gross margins, operating margins, and net margins, and no identified competitive moat, indicating the business is currently generating minimal economic value. Quality breakdown | Quality score improves above 4.0 within 12 months as specialty chemicals volumes and pricing recover from a trough. | →Stable |
| CounterSpecialty chemicals is a highly cyclical sector where margins can swing dramatically with volume utilization; current near-zero margins may reflect a cyclical trough rather than structural impairment, and recovery can be rapid when volumes improve. | ||
The stock trades at a PEG ratio of 0.02 — effectively zero — and a forward price-to-earnings of 13.9x against a peer group where the stock screens as the top value name, with analysts targeting a price approximately 38% above the current $54.47.
→Stable- Expectation
- Price rises above $63, more than 15% above the current $54.47, within 12 months as the valuation discount begins to close.
CounterAn extremely low PEG ratio alongside consecutive earnings misses often indicates the growth estimate that forms the denominator is not achievable; the cheap multiple may persist because the growth required to justify it is unlikely to materialize.
The stock has crossed into a golden cross breakout pattern — above all major moving averages with RSI at 61 and MACD bullish — and shows rising on-balance volume accumulation, suggesting institutional buyers are building positions ahead of a potential fundamental recovery.
→Stable- Expectation
- Price holds above the 200-day moving average and RSI stays above 50 for at least 60 consecutive trading days.
CounterTechnical breakouts driven by accumulation in low-quality stocks can reflect speculative rotation rather than fundamental improvement; without earnings quality improvement, breakouts in below-minimum-quality companies have a higher failure rate.
Business quality is at 2.2 out of 10, with near-zero scores on return on equity, gross margins, operating margins, and net margins, and no identified competitive moat, indicating the business is currently generating minimal economic value.
→Stable- Expectation
- Quality score improves above 4.0 within 12 months as specialty chemicals volumes and pricing recover from a trough.
CounterSpecialty chemicals is a highly cyclical sector where margins can swing dramatically with volume utilization; current near-zero margins may reflect a cyclical trough rather than structural impairment, and recovery can be rapid when volumes improve.
▸ Show 1 more pillar▾ Show fewer
The company missed earnings estimates in 3 of the last 4 quarters with an average negative surprise of -38%, including a -105% miss in February 2026 where actual EPS turned negative, indicating that forecasts remain significantly above what operations can currently deliver.
→Stable- Expectation
- EPS surprise rises above 0% in at least 2 of the next 4 quarters, confirming that the estimate reset has produced achievable targets.
CounterThe most recent quarter showed a 16.9% positive beat, which may signal the estimate reset is complete and that management has finally guided to a level that operations can achieve.
→ Full pillar scorecard with all 4 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1The stock trades at a PEG ratio of 0.02 — effectively zero — and a forward price-to-earnings of 13.9x against a peer group where the stock screens as the top value name, with analysts targeting a price approximately 38% above the current $54.47.
Trip ifAnalyst consensus price target drops below $50, more than 8% below the current $54.47, indicating downward estimate revisions are accelerating.
- P2The stock has crossed into a golden cross breakout pattern — above all major moving averages with RSI at 61 and MACD bullish — and shows rising on-balance volume accumulation, suggesting institutional buyers are building positions ahead of a potential fundamental recovery.
Trip ifPrice falls below $48, more than 12% below the current $54.47, breaking back below major moving averages and invalidating the breakout.
- P3Business quality is at 2.2 out of 10, with near-zero scores on return on equity, gross margins, operating margins, and net margins, and no identified competitive moat, indicating the business is currently generating minimal economic value.
Trip ifQuality score remains below 3.0 for more than 4 consecutive quarters, indicating no cyclical recovery in margins is occurring.
- P4The company missed earnings estimates in 3 of the last 4 quarters with an average negative surprise of -38%, including a -105% miss in February 2026 where actual EPS turned negative, indicating that forecasts remain significantly above what operations can currently deliver.
Trip ifEPS surprise falls below -30% in at least 2 of the next 4 quarters, indicating the miss streak has continued despite the recent positive beat.
How the engine reached this verdict
TrendMatrix's engine output for Stepan Company (SCL) is SELL_IF_HOLDING with medium conviction, score 4.7/10 at $54.98. An L1 hard-floor gate blocked the positive-verdict path — Quality below minimum threshold; dimensional pillars cannot lift the engine output above the verdict floor while the L1 gate is active.
The engine's exit framework anchors to a tactical sell band near $54.98, with structural invalidation at $51.88. The asymmetric R:R against a reversal hypothesis is 2.57 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).
On the bear side: Quality below floor (2.2 < 4.0). Active engine warnings: Quality below floor (2.2 < 4.0).
SELL output reflects multiple gate failures; recovery requires a confluence of those gates re-clearing, not a single dimension move.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates SCL — 10-dimension breakdown →
Bear case
- ▸Quality below floor (2.2 < 4.0)